Catalyst Wire Dossier Catalyst Wire Dossier

QUVIVIQ

daridorexant · Idorsia Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for QUVIVIQ, covering 2022-01-07 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease [Phase 4]

See pricing